Yogesh Shah, MD
Family Medicine · Des Moines, IANPI 1265510465
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Lilly USA, LLC at 52.7% of the total. Among family medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 199 payments — averaging $799.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$84K
- Eisai Inc.$72K
- Biogen$2K
- Lundbeck LLC$800
- Novo Nordisk$249
- Siemens Medical Solutions USA, Inc.$122
- plus $265 from 4 others
What the payments were for
- Consulting fees$27,44417%
- Speaking & faculty fees$93,97859%
- Travel & lodging$34,61122%
- Food & beverage$3,0592%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 92 | $83,859 |
| Eisai Inc. | 94 | $71,924 |
| Biogen | 3 | $1,872 |
| Lundbeck LLC | 1 | $800 |
| Novo Nordisk | 3 | $249 |
| Siemens Medical Solutions USA, Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $117 |
| Sunovion Pharmaceuticals Inc. | 1 | $60 |
| Life Molecular Imaging Ltd | 1 | $50 |
| Amgen | 2 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$159,091 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 379 | $4,776 |
| Donepezil Hcl | 492 | $2,946 |
| Galantamine Hbr | 37 | $1,945 |
| Aripiprazole | 13 | $1,855 |
| Memantine Hcl ErMemantine Hcl | 11 | $683 |
| Sertraline Hcl | 81 | $220 |
| Risperidone | 18 | $133 |
| Escitalopram Oxalate | 23 | $83 |
| Trazodone Hcl | 34 | $75 |
| Levothyroxine Sodium | 14 | $33 |
| Lorazepam | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Des Moines
- Thomas RossDes Moines$170K
- Dylan LoweDes Moines$105K
- Lisa KlockDes Moines$9K
- Kristin GisselmanDes Moines$8K
- Kirk PetersonHuxley$576K
- Nicholas GoetschWaterloo$525K
- Stephen HarrisonClinton$249K
- Leslie George PaulsenMuscatine$136K
- Michael AbouassalyWest Burlington$88K
- Kevin DeregnierWinterset$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.